Oct 26, 2023
Ultragenyx to Host Conference Call for Third Quarter 2023 Financial Results and Corporate Update
Read more
Oct 23, 2023
Ultragenyx Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Read more
Oct 18, 2023
Ultragenyx Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
Read more
Oct 16, 2023
Ultragenyx Announces Program and Pipeline Updates at Analyst Day Including Interim Data from Ongoing Studies in Osteogenesis Imperfecta (OI), Angelman Syndrome (AS) and Wilson Disease
Read more
Displaying 1 - 10 of 44